United States Government Publishing Office publisher pbl distributor dst United States Government Accountability Office author aut Government Organization text government publication eng GAOREPORTS Legislative Agency Publications gao legislative 2010-08-12 U.S. Government Printing Office 2008-04-04 monographic deposited born digital 37 p. GA 1.13:GAO-08-327 https://www.govinfo.gov/app/details/GAOREPORTS-GAO-08-327 P0b002ee18037a3b7 f:d08327 DGPO 2010-08-12 2011-05-04 GAOREPORTS-GAO-08-327 machine generated eng fdlp REPORT GAOREPORTS-GAO-08-327 GAO-08-327 Beneficiaries Cost analysis Defense cost control Fiscal policies Health care cost control Health care costs Health care programs Managed health care Pharmaceutical industry Prescription drugs Prices and pricing Program evaluation Program management Strategic planning Cost estimates Cost growth Program costs Program goals or objectives DOD Pharmacy Benefits Program Other Written Product A81563 Estimated to reach $15 billion by 2015, the Department of Defense's (DOD) prescription drug spending has been a growing concern for the federal government. The John Warner National Defense Authorization Act (NDAA) for Fiscal Year 2007 required GAO to examine DOD's pharmacy benefits program. Specifically, as discussed with the committees of jurisdiction, GAO examined DOD's prescription drug spending trends from fiscal years 2000 through 2006 and DOD's key efforts to limit its prescription drug spending. To conduct this work, GAO analyzed DOD's data on spending trends, including trends in beneficiary pharmacy use. GAO also assessed DOD's cost avoidance data and the agency's efforts to limit spending through its uniform formulary, which is a list of preferred drugs available to all beneficiaries. GAO interviewed DOD officials about these and other efforts to limit spending. https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-08-327/html/GAOREPORTS-GAO-08-327.htm https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-08-327/pdf/GAOREPORTS-GAO-08-327.pdf GAO-08-327 https://www.govinfo.gov/app/details/GAOREPORTS-GAO-08-327 Other Written Product GAO-08-327; DOD Pharmacy Program: Continued Efforts Needed to Reduce Growth in Spending at Retail Pharmacies; Beneficiaries Cost analysis Defense cost control Fiscal policies Health care cost control Health care costs Health care programs Managed health care Pharmaceutical industry Prescription drugs Prices and pricing Program evaluation Program management Strategic planning Cost estimates Cost growth Program costs Program goals or objectives DOD Pharmacy Benefits Program Volume 113 Page 512 113 Stat. 512 Volume 114 Page 1645A-175 114 Stat. 1645A-175 Volume 120 Page 2083 Volume 120 Page 2280 120 Stat. 2083 120 Stat. 2280 Volume 122 Page 3 122 Stat. 3 Public Law 106-65 Public Law 106-398 Public Law 109-364 Public Law 110-181